Literature DB >> 3401237

Lyso-phosphatidylcholine is implicated in thioacetamide-induced liver necrosis.

J Osada1, H Aylagas, M J Mirò-Obradors, E Palacios-Alaiz.   

Abstract

Thioacetamide is a weak hepatocarcinogen. To determine whether alterations in lysophosphatidylcholine are implicated in thioacetamide-induced hepatic necrosis, rats were injected i.p. with this agent (50 mg/Kg body weight per day) or diluent for 1, 3, 8 and 30 days. Serum catalytic activities of aminotransferases were determined. Incorporation of (32P)-orthophosphate into hepatic lysophosphatidylcholine was also evaluated in animals killed 75 minutes or 13 hours after isotope administration. Results demonstrate that: A significant increase in hepatic lysolecithin concentration occurs when a maximum level of serum aminotransferases is present. An increase of (32P)-orthophosphate radioactive incorporation in lysolecithin was observed at the two assayed labelling periods, which suggest an activation of phospholipase A. The radioactivity present in lysolecithin after 13 h isotope injection showed a close correlation with serum level of aminotransferases. From these results it can be deduced that lysolecithin is implicated in TAA-induced necrosis and may be generated by increase in either phospholipase A activity and/or synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401237     DOI: 10.1016/0006-291x(88)90211-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Effect of acute thioacetamide administration on rat brain phospholipid metabolism.

Authors:  J Osada; H Aylagas; M J Mirõ-Obradors; C Arce; E Palacios-Alaiz; M Cascales
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

2.  Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity.

Authors:  Jie Cheng; Xiaochao Ma; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2009-05-21       Impact factor: 3.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.